HACRO participated in the scientific conference organized by the National Organization for Medicines (EOF) on Wednesday, February 4, 2026, titled “The Role of EOF in Shaping Pharmaceutical Policy – The Next Steps.”
The President, Ms. Evangelia Koraki, in her presentation entitled “The pivotal role of EOF in the progress of clinical research in Greece” highlighted the multiple benefits of clinical trials for patients and the country, and emphasized the central role of EOF in protecting patients’ rights and safety, ensuring data reliability as well as enhancing Greece’s attractiveness as a destination for conducting clinical trials.
The presentation is available in the video below: